Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Genomics Raises $9M

NEW YORK — Eagle Genomics said on Monday that it has raised $9 million in funding from a group of investors led by Environmental Technologies Fund (ETF).

The investor group also included Granpool Innovated Investments, Bpd Partners, Anatom Holding, and Northeastern University researcher Albert-László Barabási.

Cambridge, UK-based Eagle said it will use the money to further develop its e[datascientist] platform, which uses artificial intelligence to analyze genomic and microbiomic data at scale for assessing the viability, efficacy, and safety of products. The company will also use the funds to continue its commercial expansion in Europe and the US.

In early 2019, Eagle closed a $3.5 million financing round, which was also led by ETF It said at the time that it would use those funds to work on e[datascientist] — formerly known as e[automateddatascientist] — and to open offices in Paris and New York.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.